Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
Filing tables
Filing exhibits
Associated BTAI transcripts
BTAI similar filings
Filing view
External links
Exhibit 31.1
CERTIFICATIONS
I, Vimal Mehta, Ph.D., certify that:
1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, of BioXcel Therapeutics, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: May 1, 2023 | By: | /s/ Vimal Mehta |
Vimal Mehta, Ph.D. | ||
President and Chief Executive Officer | ||
(Principal Executive Officer) |